Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

143.73 

0.17 0.1%

as of May 17 '21

52 Week Range:

90.47 162.70


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology and drug discovery. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '12 Dec '13 Dec '14 Oct '15 Jan '16 Oct '16 Jan '17 Oct '17 Dec '18 Dec '19 Jan '21
Equity (BVPS) 16.86
17.04
18.34
18.35
19.49
22.98
23.26
24.35
28.86
growth rate 1.1% 7.6% 0.1% 3.1% 8.6% 1.2% 4.7% 18.5%
Earnings BIT 50.59
153.33
181.10
273.27
305.99
319.63
338.17
397.87
985.50
growth rate 203.1% 18.1% 22.8% 5.8% 4.5% 5.8% 17.7% 147.7%
Avg.PE 52.91
27.86
33.81
26.04
25.87
29.49
77.50
43.35
22.33
growth rate -47.3% 21.4% -12.2% -0.3% 14.0% 162.8% -44.1% -48.5%
ROA 1.81
4.26
3.91
5.12
5.55
5.64
3.94
3.64
10.04
growth rate 135.4% -8.2% 31.0% 4.1% 0.8% -30.1% -7.6% 175.8%
ROE 3.70
8.50
7.82
10.23
10.99
12.57
9.35
8.43
22.23
growth rate 129.7% -8.0% 30.8% 3.7% 7.0% -25.6% -9.8% 163.7%
ROIC 3.50
6.86
6.36
7.88
8.55
8.24
6.65
6.04
13.96
growth rate 96.0% -7.3% 23.9% 4.2% -1.8% -19.3% -9.2% 131.1%
Cur. Ratio 1.67
1.73
1.79
1.84
1.97
1.26
1.60
1.80
1.36
growth rate 3.6% 3.5% 2.8% 3.5% -20.0% 27.0% 12.5% -24.4%
Quick Ratio 1.08
1.07
1.08
1.21
1.30
0.79
1.03
1.20
0.94
growth rate -0.9% 0.9% 12.0% 3.7% -22.1% 30.4% 16.5% -21.7%
Leverage 2.01
1.98
2.02
1.97
1.99
2.43
2.31
2.32
2.13
growth rate -1.5% 2.0% -2.5% 0.5% 10.5% -4.9% 0.4% -8.2%
Balance Sheet Dec '12 Dec '13 Dec '14 Oct '15 Jan '16 Oct '16 Jan '17 Oct '17 Dec '18 Dec '19 Jan '21
Acct.Receivable 457.01
466.75
470.56
415.06
425.59
552.30
632.67
725.18
1,155.11
growth rate 2.1% 0.8% -6.1% 1.3% 29.8% 14.6% 14.6% 59.3%
Acct.Payable 556.97
570.56
173.95
140.98
168.03
222.09
220.95
235.86
327.33
growth rate 2.4% -69.5% -10.0% 9.2% 32.2% -0.5% 6.8% 38.8%
Cur.Assets 971.75
1,044.84
1,068.55
1,033.16
1,189.93
1,199.96
1,234.63
1,374.38
2,238.92
growth rate 7.5% 2.3% -1.7% 7.3% 0.8% 2.9% 11.3% 62.9%
Total Assets 3,901.76
3,946.71
4,127.58
4,166.30
4,276.68
6,091.46
5,975.52
6,538.56
7,960.32
growth rate 1.2% 4.6% 0.5% 1.3% 42.4% -1.9% 9.4% 21.7%
Cash 171.44
173.24
174.82
237.93
359.27
202.13
163.11
191.88
402.04
growth rate 1.1% 0.9% 16.7% 22.9% -43.7% -19.3% 17.6% 109.5%
Inventory 247.69
260.86
285.46
259.49
246.85
351.68
338.35
356.94
514.57
growth rate 5.3% 9.4% -4.7% -2.5% 42.5% -3.8% 5.5% 44.2%
Cur.Liabilities 581.10
602.80
597.31
561.49
603.36
950.90
771.63
762.83
1,652.19
growth rate 3.7% -0.9% -3.1% 3.7% 57.6% -18.9% -1.1% 116.6%
Liabilities 1,961.95
1,952.23
2,085.47
2,055.85
2,123.11
3,588.28
3,390.57
3,724.74
4,224.82
growth rate -0.5% 6.8% -0.7% 1.6% 69.0% -5.5% 9.9% 13.4%
LT Debt 938.82
932.10
1,007.19
974.66
1,009.35
1,754.30
1,843.62
2,064.04
1,609.70
growth rate -0.7% 8.1% -1.6% 1.8% 73.8% 5.1% 12.0% -22.0%
Equity 1,939.81
1,994.49
2,042.10
2,110.44
2,153.57
2,503.19
2,584.96
2,813.82
3,735.49
growth rate 2.8% 2.4% 1.7% 1.0% 16.2% 3.3% 8.9% 32.8%
Common Shares 115.00
114.00
114.00
113.00
110.00
110.00
111.00
112.00
112.00
112.09
growth rate -0.9% 0.0% -0.9% -1.3% 0.0% 0.9% 0.9% 0.0% 0.1%
Cash Flow Statement Dec '12 Dec '13 Dec '14 Oct '15 Jan '16 Oct '16 Jan '17 Oct '17 Dec '18 Dec '19 Jan '21
Capital Expenditures 42.40
38.98
27.15
28.22
31.70
39.09
93.25
76.33
77.51
growth rate -8.1% -30.4% 1.9% 6.0% 23.3% 138.6% -18.2% 1.5%
Cash Dividends 31.90
31.60
31.62
31.57
30.80
30.79
31.01
31.06
31.21
growth rate -1.0% 0.1% -0.1% -1.2% 0.0% 0.7% 0.2% 0.5%
Cash From OA 152.17
158.59
281.60
287.10
350.62
288.45
311.04
363.47
892.18
growth rate 4.2% 77.6% 1.0% 10.5% -17.7% 7.8% 16.9% 145.5%
FCF per Share 0.96
0.67
2.00
2.06
2.61
2.53
1.82
1.94
4.87
growth rate -30.2% 198.5% 3.0% 12.6% -1.5% -28.1% 6.6% 151.0%
Sale Purchase of Stock 30.37
-107.09
24.46
14.91
14.42
18.00
growth rate -100.0% 100.0% -21.9% -1.7% 24.9%
FCF 110.00
119.00
253.00
257.00
258.88
319.00
318.91
249.00
218.00
282.00
815.00
growth rate 8.2% 112.6% 1.6% 0.7% 23.2% 0.0% -21.9% -12.5% 29.4% 189.0%
Income Statement Dec '12 Dec '13 Dec '14 Oct '15 Jan '16 Oct '16 Jan '17 Oct '17 Dec '18 Dec '19 Jan '21
Sales 2,105.19
2,157.59
2,069.88
2,104.82
2,115.52
2,256.98
2,778.00
2,883.67
3,782.75
growth rate 2.5% -4.1% 0.8% 0.3% 6.7% 23.1% 3.8% 31.2%
Op.Income 71.29
174.27
181.10
273.27
305.99
319.63
338.17
397.87
985.50
growth rate 144.5% 3.9% 22.8% 5.8% 4.5% 5.8% 17.7% 147.7%
IBT 55.16
163.68
123.87
208.81
244.07
296.72
257.68
237.14
906.36
growth rate 196.7% -24.3% 29.8% 8.1% 21.6% -13.2% -8.0% 282.2%
Net Income 71.29
174.27
157.78
212.43
234.30
292.63
237.93
227.56
727.89
growth rate 144.5% -9.5% 16.0% 5.0% 24.9% -18.7% -4.4% 219.9%
EPS 0.61
1.47
1.39
1.87
2.12
2.64
2.13
2.04
6.49
growth rate 141.0% -5.4% 34.5% 6.5% 11.6% -19.3% -4.2% 218.1%
Gross Profit 961.53
976.14
937.02
971.51
1,014.76
1,073.75
1,340.94
1,417.65
2,120.61
growth rate 1.5% -4.0% 1.8% 2.2% 5.8% 24.9% 5.7% 49.6%
R&D 131.84
132.40
108.06
112.54
124.18
139.46
194.00
189.34
205.39
growth rate 0.4% -18.4% 2.1% 5.1% 12.3% 39.1% -2.4% 8.5%

Quarterly Statements

Item Name Dec '19 Apr '20 Jul '20 Oct '20 Jan '21
Earnings BIT 121.92
53.80
177.68
256.80
497.25
growth rate -55.9% 230.2% 44.5% 93.6%
Balance Sheet Dec '19 Apr '20 Jul '20 Oct '20 Jan '21
Acct.Receivable 725.18
626.15
708.80
797.91
1,155.11
growth rate -13.7% 13.2% 12.6% 44.8%
Acct.Payable 235.86
233.23
255.14
258.04
327.33
growth rate -1.1% 9.4% 1.1% 26.9%
Cur.Assets 1,374.38
1,341.83
1,531.41
1,675.82
2,238.92
growth rate -2.4% 14.1% 9.4% 33.6%
Total Assets 6,538.56
6,384.40
6,636.82
6,865.57
7,960.32
growth rate -2.4% 4.0% 3.5% 16.0%
Cash 191.88
195.15
218.54
258.29
402.04
growth rate 1.7% 12.0% 18.2% 55.7%
Inventory 356.94
393.16
477.71
486.56
514.57
growth rate 10.2% 21.5% 1.9% 5.8%
Cur.Liabilities 762.83
730.14
1,163.26
1,244.80
1,652.19
growth rate -4.3% 59.3% 7.0% 32.7%
Liabilities 3,724.74
3,624.65
3,669.35
3,633.88
4,224.82
growth rate -2.7% 1.2% -1.0% 16.3%
LT Debt 2,064.04
2,010.53
1,625.00
1,492.63
1,609.70
growth rate -2.6% -19.2% -8.2% 7.8%
Equity 2,813.82
2,759.75
2,967.46
3,231.68
3,735.49
growth rate -1.9% 7.5% 8.9% 15.6%
Common Shares 110.60
111.31
111.50
111.88
112.09
growth rate 0.6% 0.2% 0.3% 0.2%
Cash Flow Statement Dec '19 Apr '20 Jul '20 Oct '20 Jan '21
Capital Expenditures 23.25
20.49
16.65
20.25
20.12
growth rate -11.9% -18.7% 21.6% -0.7%
Cash Dividends 7.78
7.78
7.79
7.81
7.83
growth rate 0.1% 0.1% 0.2% 0.3%
Cash From OA 215.21
60.05
138.60
211.43
482.10
growth rate -72.1% 130.8% 52.6% 128.0%
Sale Purchase of Stock
growth rate
FCF 191.96
39.56
121.95
191.18
461.98
growth rate -79.4% 208.2% 56.8% 141.7%
Income Statement Dec '19 Apr '20 Jul '20 Oct '20 Jan '21
Sales 805.50
652.40
811.72
964.03
1,354.61
growth rate -19.0% 24.4% 18.8% 40.5%
Op.Income 121.92
53.80
177.68
256.80
497.25
growth rate -55.9% 230.2% 44.5% 93.6%
IBT 65.30
34.69
164.83
233.76
473.09
growth rate -46.9% 375.2% 41.8% 102.4%
Net Income 64.50
33.67
137.16
176.70
380.36
growth rate -47.8% 307.4% 28.8% 115.3%
EPS
growth rate
Gross Profit 406.51
309.11
447.74
527.75
836.04
growth rate -24.0% 44.9% 17.9% 58.4%
R&D 47.64
48.91
49.52
50.13
56.82
growth rate 2.7% 1.2% 1.2% 13.4%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A+ (93.12)

YOY Growth Grade:

D (42.27)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 22.09 15.03 23.01
EPS / Growth 10.5% 9.56 19.5%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 13.8%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 10.5% 14.6% 14.6%
Future PE 20.98 24.75 24.75
Future EPS 25.92 37.29 37.29
Value Price
MOS %
134.44
-6.5%
228.13
58.7%
228.13
58.7%
MOS Price 67.22 114.06 114.06
IRT 8.89 7.85 7.85

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.